Gemcitabine plus S-1 extends OS in Japanese randomized study.
ASCO-GI 2019—NACT tops upfront surgery for PDAC in phase 2/3 trial
(...)
The resource you are trying to access is only available for registered users. To continue please login or create a FREE Univadis® account.
